The pharmaceutical industry is poised to undergo a significant transformation with the advent of software-enhanced drugs, which integrate digital components to improve patient outcomes. These innovative therapies combine traditional pharmacology with advanced prescription digital therapeutics, enabling personalized treatment plans, real-time monitoring, and adaptive dosing. By leveraging data analytics and machine learning, these drugs can offer more precise and effective interventions, marking a new era in personalized medicine. To explore this development further, read the full article on STAT News.